Advertisement

Loading...

Guangzhou Innogen Pharmaceutl Grp Co Ltd

2591.HK•HKSE
Healthcare
Biotechnology
HK$21.58
HK$1.48(7.36%)
Hong Kong Market is Open • 11:51

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) Stock Overview

Explore Guangzhou Innogen Pharmaceutl Grp Co Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.9B
P/E Ratio-25.83
EPS (TTM)$-0.89
ROE-0.40%
Fundamental Analysis

AI Price Forecasts

1 Month$18.53
3 Months$15.74
1 Year Target$0.00

2591.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -25.83 and a market capitalization of 9.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.86%
5-Day Change
6.80%
1-Month Change
-22.01%
3-Month Change
-28.73%
6-Month Change
-45.64%
Year-to-Date (YTD) Change
-28.73%
1-Year Change
-62.13%
3-Year Change
-62.13%
5-Year Change
-62.13%
All-Time (Max) Change
-62.13%

Contact Information

http://www.innogenpharm.com
NaN
NaN, Guangzhou, GD, 510010

Company Facts

IPO DateAug 15, 2025
CountryCN
Actively Trading

Frequently Asked Questions